No data to support leaving small colon polyps in place

April 26, 2007

The American Gastroenterological Association (AGA) Institute is eager to increase the number of patients who receive screening for colon cancer. There are a variety of established screening methods that are widely available, and emerging technologies, such as computed tomography colonography (CT colonography), that are under investigation. As the medical community evaluates CT colonography, the AGA Institute offers the following comments regarding the study by Pickhardt et al published in Cancer on the cost-effectiveness of colorectal cancer screening with CT colonography and the impact of not reporting diminutive lesions.

"To date, there are no long-term, adequately controlled studies that define whether leaving small polyps is truly safe. The science is not there, and only anecdotal conclusions can currently be made," says John I. Allen, MD, MBA, AGAF, incoming chair of the AGA Institute Clinical Practice & Quality Management Committee. "We are especially concerned as more literature emerges about small, flat, right-sided polyps. These were traditionally called hyperplastic polyps but now are recognized to be sessile serrated polyps that have a malignant potential. Radiologic imaging would not be expected to detect these polyps. This should remind us all of the need for meticulous evaluation, slow withdrawal and inspection of the proximal colon during optical colonoscopy."

The AGA has asked the National Institutes of Health to pursue a study to establish the clinical significance of diminutive polyps (<5mm) using adequate controls and long term follow up.

"The need to define the natural history and biological significance of small polyps is central to refining colorectal cancer screening, irrespective of modality," says Joel V. Brill, MD, AGAF, incoming chair of the AGA Institute Practice Management & Economics Committee. "We support any technology that helps more patients get screened for colorectal cancer. However, in the rush to increase screening rates, we cannot lose sight of the importance of providing patient care that is based on evidence. Right now, the data to support leaving small polyps in place is lacking."

CT colonography is an emerging technology that shows promise, but it is not widely available. Medicare and most insurance companies do not cover the test for colon cancer screening. Many practical issues associated with CT colonography still need to be addressed - including standardization of test performance, patient preparation and interpretation of test results - before CT colonography can be recommended for routine clinical practice. If a polyp that needs removal is found during CT colonography, the patient must then undergo a colonoscopy. Some patients might find it more convenient to have a single definitive optical colonoscopy. Additionally, after a patient has a negative colonoscopy, there are studies that show that it is possible to wait for 10 years for subsequent screening. There is no information on whether it is safe to wait 10 years between CT colonographies.

"Patients should not put off screening for colorectal cancer and polyps. All adults should discuss options with their physicians and be certain of their life-time risk for colon cancer. People with a family history that includes colon cancer are at higher risk, as are certain racial and ethnic populations and people with inflammatory bowel disease or previous colon polyps or cancer. By age 50, all adults should undergo one of the colorectal cancer screening tests currently available to them," says Dr. Allen.

Guidelines of multiple agencies and professional societies, including the AGA Institute, underscore the importance of screening for all individuals 50 years of age and older (younger for certain groups known to be at higher risk). Currently, there are several tests that may be used to screen for colorectal cancer, the second-leading cause of cancer deaths in the United States. Recommended tests include colonoscopy, flexible sigmoidoscopy, fecal occult blood test and barium enema.
More information about the AGA Institute Position on CT colonography is available online.

American Gastroenterological Association

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to